Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Lymphoid 1Gastrointestinal 1Dermatologic 1CNS 1

Conditions

Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Melanoma 4Endometrial Neoplasms 4Breast Neoplasms 4Uterine Cervical Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Neoplasm Metastasis 3Rectal Neoplasms 2Ovarian Neoplasms 2Lung Neoplasms 2Head and Neck Neoplasms 2Colorectal Neoplasms 2Carcinoma, Hepatocellular 2Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Rhabdomyosarcoma 1Recurrence 1Pancreatic Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Non-Squamous Non-Small Cell Lung Cancer (NSCLC) 1Multiple Myeloma 1Mouth Neoplasms 1Laryngeal Diseases 1Hodgkin Disease 1Hepatoblastoma 1Glioblastoma 1

Interventions

Nivolumab 10Doxorubicin 10Cyclophosphamide 10Vinblastine 9Radiotherapy 8Dacarbazine 8Brentuximab Vedotin 8Bleomycin 7fludarabine phosphate 6fludarabine 6Prednisone 6Etoposide 6pembrolizumab 5Melphalan 5Whole-Body Irradiation 4Vincristine 4Mycophenolic Acid 4Filgrastim 4Tacrolimus 3Radiation 3Prednisolone 3Peripheral Blood Stem Cell Transplantation 3Granulocyte Colony-Stimulating Factor 3Busulfan 3Thiotepa 2Sirolimus 2Procarbazine 2Mechlorethamine 2Bendamustine Hydrochloride 2tislelizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Active not recruiting × Hodgkin Disease × dostarlimab × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡